Fig. 5.
None or mild response rates for glabellar lines on 4-point investigator assessment over time. This figure presents results from multiple randomized registration studies. Such cross-study comparisons should be interpreted with caution due to potential differences in study design and subject characteristics. 1BOTOX® and Dysport® data derived from US Prescribing Information Phase 3 studies in glabellar lines for each neuromodulator with data available through at least Day 120 conducted separately and presented for reference only 2Beer et al [54]. DAXI DaxibotulinumtoxinA for Injection